The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

By Craig S. Wong, S. Jelacic, Rebecca L. Habeeb, S. Watkins, P. Tarr. New England Journal of Medicine, 2000

1,071 citations recorded by the source corpus.

Subfields: Endocrinology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/89dc94733ed2c92527e25ddd4456186c5d995688

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Tarr
2. H. Karch
3. M. Bielaszewska
4. A. Friedrich
5. R. Tauxe
6. R. Guerrant
7. P. Griffin
8. L. Reller

Citations in the corpus

• Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. (2002, background): “HUS was defined as hemolytic anemia (hematocrit ,30%, with evidence of the destruction of erythrocytes on a peripheral blood smear), thrombocytopenia (platelet count ,150,000 cells/mm(3)), and renal insufficiency (a serum creatinine concentration that exceeded the upper limit of the normal range for”
• Practice guidelines for the management of infectious diarrhea. (2001, background): “coli O157:H7 infections may be increased when certain antibiotics are used to treat the initial diarrhea [44–58].”